Kura Oncology, Inc.
Key Metrics
Market Snapshot
About
Kura Oncology is a clinical-stage biopharmaceutical company developing precision medicines for cancer treatment. The company's lead candidates include menin inhibitors for acute leukemias and farnesyl transferase inhibitors for solid tumors with specific genetic mutations. Kura focuses on genetically defined patient populations where targeted therapies can provide significant clinical benefit.